Moi Bhattacharyya's Avatar

Moi Bhattacharyya

@moitrayee-lab.bsky.social

science enthusiasts in Pharmacology @Yale studying molecular mechanisms of cell signaling in cancer, pain, and neurodegeneration (https://www.bhattacharyya-lab.org/)

55 Followers  |  55 Following  |  8 Posts  |  Joined: 25.11.2024  |  1.737

Latest posts by moitrayee-lab.bsky.social on Bluesky

Super cool! Congratulations!

22.11.2025 19:07 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Flyer for the Yale Pharmacology Seminar Series 2025โ€“2026. This flyer indicates that Moi Bhattacharyya, PhD will be presenting her work at 12 pm on Thursday, November 20, 2025 in the Brady Auditorium. Dr. Bhattacharyya is an Assistant Professor of Pharmacology at Yale School of Medicine. The title of her talk is "Nanoscale Analyses of Membrane Proteins in Neurodegeneration and Pain."

Flyer for the Yale Pharmacology Seminar Series 2025โ€“2026. This flyer indicates that Moi Bhattacharyya, PhD will be presenting her work at 12 pm on Thursday, November 20, 2025 in the Brady Auditorium. Dr. Bhattacharyya is an Assistant Professor of Pharmacology at Yale School of Medicine. The title of her talk is "Nanoscale Analyses of Membrane Proteins in Neurodegeneration and Pain."

Join us in welcoming our next 2025โ€“2026 Pharmacology Seminar Series speaker: our very own Dr. Moi Bhattacharyya! She will be presenting her work at 12 pm on Thursday, November 20th in the Brady Auditorium.

19.11.2025 19:08 โ€” ๐Ÿ‘ 3    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 1

Stay tuned for a longer, step-by-step description of our work!

18.11.2025 23:28 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Phosphoinositide 3-kinase regulates wild-type RAS signaling to confer resistance to KRAS inhibition Despite the availability of RAS inhibitors and the dependence of >90% of pancreatic ductal adenocarcinomas (PDAC) on oncogenic KRAS mutations, resistance to KRAS inhibition remains a serious obstacle....

1/๐Ÿšจ New preprint out!๐Ÿšจ
We uncovered that #PI3K-driven wild-type RAS activation bypasses #KRAS inhibition in pancreatic adenocarcinoma (#PDAC) to drive #resistance.
๐Ÿ”‘PI3K isnโ€™t just a downstream RAS effector โ€“ it can be an upstream RAS regulator.
๐Ÿ“„ www.biorxiv.org/content/10.1...

25.06.2025 19:32 โ€” ๐Ÿ‘ 8    ๐Ÿ” 2    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 1

Excited to attend and speak at the GRC grc.org/neurotrophic-mโ€ฆ about our work on NGF receptor TrkA @yalepharm.bsky.social @yaleschoolofmed.bsky.social! Dr. Shailesh Kumar from my lab is also presenting a poster. Looking forward to hearing about cool new discoveries in the area!

01.06.2025 17:22 โ€” ๐Ÿ‘ 1    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Thank you David!

03.04.2025 17:04 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Thank you @hypothesisfund.bsky.social and @krishnanyamuna.bsky.social for this opportunity to shed โ€˜lightโ€™ on membrane contacts! Honored to be part of this and congratulations to my fellow awardees. Canโ€™t wait to start this scientific adventure @yalepharm.bsky.social @yaleschoolofmed.bsky.social!

03.04.2025 16:38 โ€” ๐Ÿ‘ 5    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 1

Very excited to host Dr. Stephen Sligar this Thursday! Anyone doing membrane protein biophysics will immediately recognize his immense contributions in enabling reconstitution of membrane proteins in lipid nanodiscs and subsequent applications! Hope to see many of you there!

25.02.2025 03:46 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

ร…NGSTRร–M-RESOLUTION IMAGING OF CELL-SURFACE GLYCANS ๐Ÿฌ๐Ÿญ๐Ÿ”ฌ

For the first time, weโ€™re able to study the molecular architecture of the glycocalyx at single-sugar resolutionโ€”a longstanding challenge in glycobiology! #glycotime

Preprint and #bluetorial below!!

11.02.2025 11:29 โ€” ๐Ÿ‘ 30    ๐Ÿ” 10    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 1

I am excited to host @eboyden3.bsky.social for a seminar in @yalepharm.bsky.social on Thursday, Feb 13. I hope to see many of you there!

10.02.2025 19:48 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain The FDA approved Journavx (suzetrigine) 50 mg oral tablets, a first-in-class non-opioid analgesic to treat moderate to severe acute pain in adults.

@fda.govFDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain www.fda.gov/news-events/...

31.01.2025 00:34 โ€” ๐Ÿ‘ 1    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
A temperature-inducible protein module for control of mammalian cell fate - Nature Methods The Melt (Membrane localization using temperature) protein translocates to the plasma membrane upon temperature shift. Melt variants with a range of switching temperatures enable straightforward therm...

Every once in a while we publish a paper that moves a whole field forward. I think that's the case for this one from the Bugaj lab, where they describe proteins for THERMOGENETIC control of cellular behavior. www.nature.com/articles/s41...

23.01.2025 18:34 โ€” ๐Ÿ‘ 1214    ๐Ÿ” 149    ๐Ÿ’ฌ 37    ๐Ÿ“Œ 13
Preview
Synthetic GPCRs for programmable sensing and control of cell behaviour - Nature Modular synthetic G-protein-coupled receptors with nanobody-based ligand-recognition domains can be designed and used to programme transgene expression, real-time fluorescence or endogenous G-protein ...

Amazing new work from the lab of @aliceyting.bsky.social @stanfordmedicine.bsky.social @stanfordbiosci.bsky.social, engineered GPCRs for ligand-activated cell responses

www.nature.com/articles/s41...

05.12.2024 14:02 โ€” ๐Ÿ‘ 189    ๐Ÿ” 32    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 2
Post image

Book rec: Neanderthal Man by 2022 @nobelprize.bsky.social laureate Svante Pรครคbo. A fascinating dive into sequencing ancient ๐Ÿงฌ. Captures the thrills, setbacks, and Pรครคboโ€™s personal vulnerabilities during groundbreaking science.

02.12.2024 23:23 โ€” ๐Ÿ‘ 52    ๐Ÿ” 6    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0

Hugs and prayers for a quick recovery ๐Ÿ’œ

27.11.2024 19:44 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

@moitrayee-lab is following 20 prominent accounts